105 filings
8-K
MAXY
Maxygen Inc
30 Aug 13
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
MAXY
Maxygen Inc
13 Aug 13
Maxygen Announces Approval of Dissolution by Shareholders
12:00am
8-K
MAXY
Maxygen Inc
7 Aug 13
Maxygen Reports Second Quarter 2013 Financial Results
12:00am
8-K
MAXY
Maxygen Inc
3 Jun 13
Maxygen Announces Board Decision to Dissolve the Company
12:00am
8-K
MAXY
Maxygen Inc
3 May 13
Maxygen Reports First Quarter 2013 Financial Results
12:00am
8-K
8iu0utbsgzazehyjg zw
12 Mar 13
Maxygen Reports Fourth Quarter and Year End 2012 Financial Results
12:00am
8-K
yu2x9tr5qj 7e0mdzq2k
16 Nov 12
Other Events
12:00am
8-K
3bmzt e3niwba6l
6 Nov 12
Maxygen Announces Third Quarter 2012 Financial Results
12:00am
8-K
zat3r9
7 Aug 12
Maxygen Announces Second Quarter 2012 Financial Results and Business Update
12:00am
8-K
pse5f 6evoe
7 Jun 12
Submission of Matters to a Vote of Security Holders
12:00am
8-K
7mcxbd4qxv6qf
14 May 12
Maxygen to Receive $30 Million Payment from Bayer
12:00am
8-K
gx49n
7 May 12
Maxygen Reports First Quarter 2012 Financial Results
12:00am
8-K
1ttq k3yjl
8 Mar 12
Maxygen Reports Fourth Quarter and Year End 2011 Financial Results
12:00am
8-K
bi131i jddpfa3gk7687
26 Jan 12
Other Events
12:00am
8-K
9183l08q3 b2
9 Nov 11
Development of MAXY-G34 for Acute Radiation Syndrome
12:00am
8-K
repv esbfet
7 Nov 11
Maxygen Reports Third Quarter 2011 Financial Results
12:00am
8-K
btvofs68f zf
11 Oct 11
Maxygen Announces Final Rejection of All Claims of Amgen ‘804 Patent in Inter Partes Reexamination Proceeding
12:00am
8-K
sn5jd2 4xwynnamc
8 Aug 11
Maxygen Reports Second Quarter 2011 Financial Results
12:00am
8-K
aexng7 86q
31 May 11
Maxygen Announces $10 Million Stock Repurchase Program
12:00am
8-K
ka7lscn 786hgt
20 May 11
Entry into a Material Definitive Agreement
12:00am